Overview
Paper 2 Assignment: Write a paper that provides an update on biological chemistry and pharmacology of a recently approved drug (choices to be provided): You have landed a job as a lab research scientist. The head of the lab is interested in a particular class of drug and asks you to write a mini-review (1200 - 1500 words, may include figures/tables/diagrams from literature) for other scientists in the lab. This review might even become a published update in a journal in your field, who knows! Write your paper based on class discussions and key literature (two or more papers) to be provided by the instructor.
- BRIUMVI (ublituximab-xiiy) for MS
- LEQEMBI (lecanemab-irmb) for Alzheimer’s disease
- LEQVIO - inclisiran
- MOUNJARO or ZEPBOUND (Tirzepatide)
- ORSERDU Elacestrant for ER+ Breast Cancer
- Zurzuvae - zuranolone for post-partum depression
- Belsomra - suvorexant
- Corlanor - ivabradine
- Entresto - sacubutril valsartan
- Entyvio - vedolzumab
- Evolocumab Repatha
- Imlygic - talimogene laherparepvec
- Kadcyla - ado-trastuzumab emtansine
- Kanuma - sebelipase alfa
- Kybella - deoxycholic acid
- Nucala - mepolizumab
- Opdivo nivolumab - PD-L1
- Otezla - apremilast
- Rinvoq - Upadacitinib
- Tanzeum - albiglutide
These are topics